Medication Adherence for Complex Chronic Patients

FQHC patients managing diabetes, hypertension, heart failure, COPD, and chronic kidney disease — often in combination — face a medication adherence environment that is structurally more difficult than the general population. Polypharmacy complexity means multiple medications with different dosing schedules, different side effect profiles, and different prescribers who may not be coordinating with each other. Cost barriers mean that even a small copay change can create a decision between a medication and a bill. Language barriers mean that instructions on a prescription label may not be fully understood.

A patient who stopped taking their lisinopril because it caused a persistent dry cough and did not know that the cough was a known side effect with alternative medications available represents a preventable adherence gap. A patient who is taking their metformin intermittently because they cannot afford to fill it every month represents a different kind of adherence gap requiring a different response. A patient who is taking their medication correctly but filling it at a pharmacy not connected to the FQHC's claims system appears non-adherent in the data without being non-adherent in reality.

Each of these situations requires a two-way conversation to identify. A refill reminder system that sends a notification when the prescription fill window opens does not have that conversation. It confirms the prescription exists and the fill window is open. It does not know — and cannot ask — what is actually happening with the medication and why.

The Medication Adherence workflow within the Chronic and Longitudinal Care Management Agent conducts two-way outreach with FQHC patients managing complex chronic conditions — capturing current medication status, identifying the specific barrier to adherence, and routing the resolution to the appropriate resource. Side effect concerns route to the pharmacist or prescribing provider. Cost barriers route to the patient assistance program or formulary review workflow. Multi-prescriber conflicts route to the care coordinator for medication reconciliation. Language or comprehension barriers are addressed in the patient's primary language in the same interaction.

ZynReminder manages the follow-up contact for patients whose barrier required a resolution that takes time — a pharmacist callback, a cost assistance application, a prescription change. Every interaction is documented with the barrier type, the routing action, and the resolution outcome, giving the clinical team a structured view of why adherence gaps are occurring across the chronic disease population.

For FQHCs where medication adherence is tracked as a quality metric and where preventable adverse events from non-adherence represent both clinical harm and financial cost, the change is in how many adherence barriers are identified and resolved versus how many result in an acute clinical event that was preventable with the right intervention.